US1014986A
(en)
|
1910-01-03 |
1912-01-16 |
Alfred J Ware |
Printing-machine.
|
US1014987A
(en)
|
1910-12-12 |
1912-01-16 |
B L Shrader |
Gang-plow.
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
US4789734A
(en)
|
1985-08-06 |
1988-12-06 |
La Jolla Cancer Research Foundation |
Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
|
CH671155A5
(zh)
|
1986-08-18 |
1989-08-15 |
Clinical Technologies Ass |
|
US5143845A
(en)
*
|
1986-09-03 |
1992-09-01 |
Toa Pharmaceutical Co., Ltd. |
Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
DE68928665T2
(de)
|
1988-08-02 |
1998-11-12 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
JPH08505625A
(ja)
|
1993-01-11 |
1996-06-18 |
ダナ−ファーバー キャンサー インスティチュート |
細胞毒性tリンパ球応答の誘導
|
GB9306473D0
(en)
|
1993-03-29 |
1993-05-19 |
Bioglan Lab Ltd |
Pharmaceutically useful compounds
|
US6241983B1
(en)
|
1994-10-28 |
2001-06-05 |
Metagenics, Inc. |
Bacteria-and fiber-containing composition for human gastrointestinal health
|
US5531989A
(en)
|
1994-10-28 |
1996-07-02 |
Metagenics, Inc. |
Immunoglobulin and fiber-containing composition for human gastrointestinal health
|
JPH08298982A
(ja)
*
|
1995-05-02 |
1996-11-19 |
Aasu Giken:Kk |
複合微生物製剤
|
CA2269806C
(en)
|
1996-10-28 |
2006-01-24 |
Bernhard H. Van Lengerich |
Embedding and encapsulation of controlled release particles
|
US7767203B2
(en)
*
|
1998-08-07 |
2010-08-03 |
Ganeden Biotech, Inc. |
Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
|
SK3482001A3
(en)
|
1998-09-17 |
2002-02-05 |
Baxter Healthcare Sa |
Streptococcal c beta protein compositions
|
AU1543400A
(en)
|
1998-12-11 |
2000-07-03 |
Urex Biotech Inc. |
Oral administration of lactobacillus for the treatment and prevention of urogenital infection
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US7056661B2
(en)
|
1999-05-19 |
2006-06-06 |
Cornell Research Foundation, Inc. |
Method for sequencing nucleic acid molecules
|
WO2001011015A1
(en)
|
1999-08-05 |
2001-02-15 |
Societe Des Produits Nestle S.A. |
New bifidobacteria preventing diarrhea caused by pathogenic bacteria
|
JP4580542B2
(ja)
|
2000-05-17 |
2010-11-17 |
株式會社バイオニア |
肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
FI110668B
(fi)
|
2000-06-20 |
2003-03-14 |
Aboatech Ab Oy |
Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
DE10043151A1
(de)
*
|
2000-08-31 |
2002-03-28 |
Peter Steinruecke |
Knochenzement mit antimikrobieller Wirksamkeit
|
EP1227152A1
(en)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
KR100845456B1
(ko)
|
2001-02-06 |
2008-07-10 |
소시에떼 데 프로듀이 네슬레 소시에떼아노님 |
젖산균 및 비피도균에 의한 내독소 결합
|
WO2002085415A1
(en)
|
2001-04-17 |
2002-10-31 |
Biomatrix, Inc |
Non-digestible sugar-coated products and process
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
BR0307875B1
(pt)
|
2002-02-21 |
2014-12-23 |
Nestle Sa |
Uso de uma bactéria pró-biótica de ácido láctico ou de um sobrenadante de cultura da mesma e um carotenóide para a preparação de uma composição para a fotoproteção da pele
|
ITBO20020564A1
(it)
|
2002-09-06 |
2004-03-07 |
Alfa Wassermann Spa |
Bifidobatteri e preparazioni che li contengono.
|
SE526711C2
(sv)
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
|
US8617870B2
(en)
|
2003-03-13 |
2013-12-31 |
University Of Ottawa |
Antioxidant producing bacterium and uses thereof
|
GB0307026D0
(en)
|
2003-03-27 |
2003-04-30 |
Rowett Res Inst |
Bacterial supplement
|
EP1462116A1
(en)
|
2003-03-29 |
2004-09-29 |
Villitech SARL |
Composition for treating the gastrointestinal tract
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US20050100559A1
(en)
|
2003-11-07 |
2005-05-12 |
The Procter & Gamble Company |
Stabilized compositions comprising a probiotic
|
EP1600060A1
(en)
|
2004-05-25 |
2005-11-30 |
Cognis IP Management GmbH |
Oral and/or topical compositions comprising prebiotics and fatty acid
|
JP2008503563A
(ja)
|
2004-06-23 |
2008-02-07 |
ロレアル |
敏感及び/又は乾燥肌の予防及び/又は処置に有用な方法及び組成物
|
CA2471142A1
(fr)
|
2004-06-25 |
2005-12-25 |
Pierre Marcotte |
Ressort a comportement controle
|
US7862808B2
(en)
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
ITMI20041550A1
(it)
|
2004-07-29 |
2004-10-29 |
Proge Farm Srl |
Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
|
FR2874825B1
(fr)
|
2004-09-08 |
2006-12-08 |
Genibio Sarl |
Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
EP1812068A4
(en)
|
2004-10-29 |
2010-06-09 |
Medimmune Inc |
METHODS FOR PREVENTING AND TREATING RSV INFECTIONS AND ASSOCIATED DISEASES
|
JP5565991B2
(ja)
|
2004-12-15 |
2014-08-06 |
株式会社島津製作所 |
微生物菌種推定システム及び方法
|
US8728794B2
(en)
|
2004-12-28 |
2014-05-20 |
Meiji Seika Pharma Co., Ltd. |
Strain conferring anti-disease properties to host and bacterial cell composition
|
TW200700074A
(en)
|
2005-03-04 |
2007-01-01 |
Calpis Co Ltd |
Inducer of t cell apoptosis
|
US20060223153A1
(en)
|
2005-04-05 |
2006-10-05 |
Luca Technologies, Llc |
Generation of materials with enhanced hydrogen content from anaerobic microbial consortia
|
US8501463B2
(en)
|
2005-05-03 |
2013-08-06 |
Anaerobe Systems |
Anaerobic production of hydrogen and other chemical products
|
JP2006314219A
(ja)
*
|
2005-05-11 |
2006-11-24 |
Asahi Breweries Ltd |
腸内細菌を利用した胆汁酸の吸着方法、および胆汁酸吸着物質
|
JP2007031291A
(ja)
*
|
2005-07-22 |
2007-02-08 |
Ace Bio Product Kk |
体重増加抑制剤及び体重増加抑制飲料
|
FR2889958A1
(fr)
|
2005-08-25 |
2007-03-02 |
Lyoct Sa Lab |
Utilisation d'un symbiotique pour le traitement de la dermatite atopique
|
EP1776877A1
(en)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Method for stimulating the intestinal flora
|
PL1981516T3
(pl)
*
|
2006-01-27 |
2019-03-29 |
Dupont Nutrition Biosciences Aps |
Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
|
ITRM20060237A1
(it)
|
2006-05-03 |
2007-11-04 |
Anabasis S R L |
Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche
|
CA2652559A1
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Biotherapeutic compositions and uses thereof
|
CN1850047A
(zh)
|
2006-06-01 |
2006-10-25 |
济南帅华医药科技有限公司 |
一种含β-内酰胺酶抑制剂和头孢菌素的缓释制剂及其应用
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
CN101095698B
(zh)
|
2006-06-26 |
2010-12-01 |
青岛东海药业有限公司 |
酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
|
US7867578B2
(en)
*
|
2006-06-28 |
2011-01-11 |
Applied Materials, Inc. |
Method for depositing an amorphous carbon film with improved density and step coverage
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
US20100172874A1
(en)
|
2006-12-18 |
2010-07-08 |
The Washington University |
Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
DE112007003464A5
(de)
|
2007-02-22 |
2010-01-21 |
SCHREZENMEIR, Jürgen |
Probiotische, Gram-positive Bakterien zur Prophylaxe, Unterdrückung oder Eliminierung von allergischen Reaktionen bei Menschen
|
US9644210B2
(en)
|
2007-02-22 |
2017-05-09 |
Jürgen Schrezenmeir |
Probiotic gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in human
|
CN101688171B
(zh)
|
2007-03-28 |
2013-03-27 |
营养健康有限公司 |
益生双歧杆菌菌株
|
NZ580006A
(en)
|
2007-03-28 |
2012-03-30 |
Alimentary Health Ltd |
Probiotic bifidobacterium strain 41387
|
CA2684713C
(en)
|
2007-05-03 |
2019-02-19 |
Tobias Olofsson |
Lactobacillus or bifidobacterium isolated from honey or honey producing tracts of honey bees
|
TW200904340A
(en)
|
2007-05-11 |
2009-02-01 |
Mannatech Inc |
Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
|
DK1992351T3
(en)
|
2007-05-18 |
2016-06-06 |
Nestec Sa |
Lactobacillus johnsonii for the prevention of post-surgical infection
|
US20090010891A1
(en)
*
|
2007-07-06 |
2009-01-08 |
Toa Pharmaceutical Co., Ltd. |
Sepsis Treatment Agent
|
US20090010892A1
(en)
*
|
2007-07-06 |
2009-01-08 |
Toa Pharmaceutical Co., Ltd. |
Hyperlipidemia Treatment Agent
|
US7919250B2
(en)
|
2007-07-31 |
2011-04-05 |
New York University |
Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
WO2009043856A2
(en)
|
2007-10-01 |
2009-04-09 |
University College Cork, National University Of Ireland, Cork |
Modulation of tissue fatty acid composition of a host by human gut bacteria
|
US8478544B2
(en)
|
2007-11-21 |
2013-07-02 |
Cosmosid Inc. |
Direct identification and measurement of relative populations of microorganisms with direct DNA sequencing and probabilistic methods
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
ES2343499B1
(es)
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
EP2110028A1
(en)
|
2008-04-15 |
2009-10-21 |
Nestec S.A. |
Bifidobacterium longum and hippocampal BDNF expression
|
US20110189149A1
(en)
|
2008-06-20 |
2011-08-04 |
Remy Burcelin |
New Uses of Lactic Acid Bacteria and Bifidobacteria
|
EP2318513B1
(en)
|
2008-07-11 |
2012-09-19 |
Chr. Hansen A/S |
New probiotic bifidobacterium longum
|
US8569466B2
(en)
|
2008-09-10 |
2013-10-29 |
Nnochiri Ekwuribe |
Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
|
EP2337569A4
(en)
|
2008-09-25 |
2013-04-03 |
Univ New York |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE GASTROINTESTINAL, SKIN AND NASAL MICROBIOTA
|
WO2010040055A2
(en)
|
2008-10-03 |
2010-04-08 |
Intekrin Therapeutics, Inc. |
Oral pharmaceutical formulations for antidiabetic compounds
|
PL2352389T3
(pl)
|
2008-11-11 |
2016-07-29 |
Alimentary Health Ltd |
Bifidobacterium longum
|
JP5606672B2
(ja)
|
2008-11-26 |
2014-10-15 |
太陽化学株式会社 |
シンバイオティクスを利用した腸内環境調整方法
|
WO2010096550A2
(en)
|
2009-02-18 |
2010-08-26 |
University Of Florida Research Foundation, Inc. |
Lactobacillus supplement for alleviating type 1 diabetes
|
KR20170053733A
(ko)
*
|
2009-02-24 |
2017-05-16 |
리터 파마슈티컬즈 인코오포레이티드 |
프리바이오틱 제제 및 사용 방법
|
US20100086981A1
(en)
|
2009-06-29 |
2010-04-08 |
Qteros, Inc. |
Compositions and methods for improved saccharification of biomass
|
US20120027737A1
(en)
|
2009-03-25 |
2012-02-02 |
Chr-Hansen A/S |
Use of probiotics to ameliorate diet-induced insulin resistance
|
WO2010108950A1
(en)
*
|
2009-03-25 |
2010-09-30 |
Chr. Hansen A/S |
Use of a probiotic to regulate body weight
|
CA2761150C
(en)
|
2009-05-07 |
2017-06-13 |
Tate & Lyle Ingredients France SAS |
Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
|
MY159273A
(en)
|
2009-05-11 |
2016-12-30 |
Nestec Sa |
Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
|
DK3181134T3
(da)
|
2009-06-19 |
2020-01-20 |
Dupont Nutrition Biosci Aps |
Bifidobakterier til behandling af diabetes og relaterede tilstande
|
US20150320808A1
(en)
|
2009-06-19 |
2015-11-12 |
Dupont Nutrition Biosciences Aps |
Bifidobacteria for treating cardiac conditions
|
US9848760B2
(en)
|
2009-06-29 |
2017-12-26 |
Gearbox, Llc |
Devices for continual monitoring and introduction of gastrointestinal microbes
|
US20120129794A1
(en)
|
2009-07-24 |
2012-05-24 |
Dowd Scot E |
Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
|
ES2708450T3
(es)
|
2009-07-30 |
2019-04-09 |
Dupont Nutrition Biosci Aps |
Bacterias ácido lácticas y bifidobacterias para tratar endotoxemia
|
ES2664828T3
(es)
|
2009-08-25 |
2018-04-23 |
Nestec S.A. |
Bifidobacterium longum y trastornos GI funcionales
|
CA2776420A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
KR100962365B1
(ko)
|
2009-10-07 |
2010-06-10 |
주식회사 대일 |
활어수송용 컨테이너
|
CA2777941C
(en)
|
2009-11-12 |
2018-08-14 |
Nestec S.A. |
Nutritional composition for promoting gut microbiota balance and health
|
ES2648055T3
(es)
|
2009-12-16 |
2017-12-28 |
Probiotical S.P.A. |
Cepas de bacterias probióticas que producen ácido linoleico conjugado y uso de las mismas para la preparación de una composición farmacéutica
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
EP2556835B1
(en)
|
2010-02-10 |
2015-08-05 |
Japan Eco-Science Co. Ltd. |
Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
|
AU2011223049B2
(en)
|
2010-03-01 |
2015-06-18 |
Institut National De La Recherche Agronomique |
Method of diagnostic of inflammatory bowel diseases
|
CA2791464A1
(en)
|
2010-03-01 |
2011-09-09 |
Institut National De La Recherche Agronomique |
Method of diagnosis of obesity
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
JP5799083B2
(ja)
*
|
2010-04-12 |
2015-10-21 |
エルジー エレクトロニクス インコーポレイティド |
多重アンテナ支援無線通信システムにおいて効率的なフィードバック方法及び装置
|
WO2011137249A1
(en)
|
2010-04-28 |
2011-11-03 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
FI20105478A0
(fi)
|
2010-04-30 |
2010-04-30 |
Valtion Teknillinen |
Menetelmä tyypin 1 diabeteksen diagnosoimiseksi ja menetelmiä ja koostumuksia tyypin 1 diabeteksen puhkeamisen estämiseksi
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
US9439933B2
(en)
|
2010-06-28 |
2016-09-13 |
Kabushiki Kaisha Yakult Honsha |
Skin properties improving agent for oral administration
|
BR112012033079B1
(pt)
|
2010-06-30 |
2018-11-06 |
Nestec S.A. |
usos cosméticos de ácido chicórico e seus derivados
|
WO2012021678A2
(en)
*
|
2010-08-12 |
2012-02-16 |
The Administrators Of The Tulane Educational Fund |
Isolated bacteria, methods for use, and methods for isolation
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2012033814A2
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
ES2663627T3
(es)
|
2010-10-11 |
2018-04-16 |
Jennewein Biotechnologie Gmbh |
Fucosiltransferasas novedosas y sus aplicaciones
|
US20120165792A1
(en)
|
2010-12-22 |
2012-06-28 |
Ethicon Endo-Surgery, Inc. |
Pill Catchers
|
CN103415295A
(zh)
*
|
2010-12-29 |
2013-11-27 |
雀巢产品技术援助有限公司 |
用于减少与压力相关的肠症状的纤维和益生菌
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
US9504739B2
(en)
|
2011-03-01 |
2016-11-29 |
Quorum Innovations, Llc |
Method of identifying a biologically-active composition from a biofilm
|
EP3610881A1
(en)
|
2011-03-09 |
2020-02-19 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
CN102254089A
(zh)
|
2011-04-18 |
2011-11-23 |
王钰 |
一种体系仿真方法和系统
|
ITMI20110793A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
|
JP5877902B2
(ja)
|
2011-08-17 |
2016-03-08 |
マイクロバイオーム セラピューティクス,エルエルシー |
バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
|
US9493737B2
(en)
|
2011-08-18 |
2016-11-15 |
Chr. Hansen A/S |
Method for purifying bacterial cells
|
KR101982491B1
(ko)
*
|
2011-08-30 |
2019-05-27 |
아카데미쉬 메디쉬 센트륨 |
인슐린 저항 예방 및/또는 치료 방법
|
CA2848762C
(en)
|
2011-09-14 |
2021-07-27 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
GB201117313D0
(en)
*
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
FI20116008A0
(fi)
|
2011-10-12 |
2011-10-12 |
Maeyrae Maekinen Annika |
Viskeraalisen rasvan estäminen ja diagnostisointi
|
US9649346B2
(en)
|
2011-11-02 |
2017-05-16 |
Bios Llc |
Probiotic stick formulation for skin maintenance and methods of use
|
CN104159588A
(zh)
|
2011-11-04 |
2014-11-19 |
通用工厂公司 |
用于调节胃肠细菌以促进健康的方法和组合物
|
CN116942833A
(zh)
|
2011-12-01 |
2023-10-27 |
国立大学法人 东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
CA2861533C
(en)
|
2011-12-07 |
2020-07-14 |
Calpis Co., Ltd. |
Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
|
WO2013107913A1
(en)
|
2012-01-19 |
2013-07-25 |
University College Cork - National University Of Ireland, Cork |
Gaba-producing culturable bacteria derived from the human gastrointestinal tract
|
US9173910B2
(en)
|
2012-02-29 |
2015-11-03 |
The General Hospital Corporation |
Compositions of microbiota and methods related thereto
|
ES2436251B1
(es)
|
2012-05-25 |
2014-10-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
|
US20130344042A1
(en)
|
2012-06-20 |
2013-12-26 |
Gretchen Tanbonliong |
Dietary management of celiac disease and food allergy
|
WO2014011233A1
(en)
*
|
2012-07-09 |
2014-01-16 |
Trachtman Ira Milton |
Compositions and method for treatment and prophylaxis of inflammatory bowel disease
|
US10093894B2
(en)
|
2012-08-20 |
2018-10-09 |
Chr. Hansen A/S |
Method for optimizing a process for freeze drying a bacteria-containing concentrate
|
ES2770401T3
(es)
*
|
2012-09-20 |
2020-07-01 |
Prothera Inc |
Composiciones probióticas para el tratamiento de la obesidad y afecciones relacionadas con la obesidad
|
EP3345606A1
(en)
|
2012-11-01 |
2018-07-11 |
Rijksuniversiteit Groningen |
Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
|
WO2014075745A1
(en)
*
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
EP3967315A1
(en)
|
2012-11-19 |
2022-03-16 |
Université catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
DK3628161T3
(da)
|
2012-11-23 |
2023-05-30 |
Seres Therapeutics Inc |
Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
|
WO2014088982A1
(en)
|
2012-12-07 |
2014-06-12 |
Albert Einstein College Of Medicine Of Yeshiva University |
Gut barrier dysfunction treatment and prevention
|
EP3584308A3
(en)
|
2013-02-04 |
2020-03-04 |
Seres Therapeutics, Inc. |
Compositions and methods
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
CN105228635A
(zh)
|
2013-03-05 |
2016-01-06 |
格罗宁根大学 |
Faecalibacterium prausnitzii HTF-F(DSM 26943)在抑制炎症中的应用
|
EP2971148A4
(en)
|
2013-03-14 |
2016-08-17 |
Seres Therapeutics Inc |
METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS
|
JP6464142B2
(ja)
*
|
2013-03-14 |
2019-02-06 |
セラバイオーム,エルエルシー |
プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
|
US10716802B2
(en)
|
2013-03-15 |
2020-07-21 |
The Brigham And Women's Hospital, Inc. |
Compounds to modulate intestinal absorption of nutrients
|
CA2906921A1
(en)
|
2013-03-15 |
2014-09-18 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
US11814664B2
(en)
|
2013-05-24 |
2023-11-14 |
Genomatica, Inc. |
Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate
|
WO2014201037A2
(en)
|
2013-06-10 |
2014-12-18 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
KR101470513B1
(ko)
|
2013-07-17 |
2014-12-08 |
주식회사 아모그린텍 |
대전류 직류중첩특성 및 코어손실 특성이 우수한 연자성 코어 및 그의 제조방법
|
CN105407728A
(zh)
|
2013-07-21 |
2016-03-16 |
霍勒拜欧姆公司 |
用于微生物组表征、监测和治疗的方法和系统
|
WO2015051323A1
(en)
|
2013-10-03 |
2015-04-09 |
Trustees Of The University Of Pennsylvania |
Compositions comprising a defined microbiome and methods of use thereof
|
US10058576B2
(en)
|
2013-10-03 |
2018-08-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods comprising a defined microbiome and methods of use thereof
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
GB201319531D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition & methods of screening
|
GB201319539D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition & methods of screening
|
GB201319538D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition
|
GB201319525D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition
|
GB201319540D0
(en)
|
2013-11-05 |
2013-12-18 |
Optibiotix Health Ltd |
Composition
|
MX367109B
(es)
|
2013-11-25 |
2019-08-05 |
Seres Therapeutics Inc |
Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
|
KR20150066772A
(ko)
|
2013-12-09 |
2015-06-17 |
주식회사 쎌바이오텍 |
신규한 유산균 및 이를 포함하는 영유아의 설사병 예방 또는 치료용 조성물
|
EP3082431A4
(en)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
WO2015089674A1
(en)
|
2013-12-20 |
2015-06-25 |
9286-3620 Québec Inc. |
Protein-based enteric coating for oral dosage forms
|
CN105828641A
(zh)
|
2013-12-20 |
2016-08-03 |
雀巢产品技术援助有限公司 |
用于减少肠病原体的营养组合物
|
EP3102670A4
(en)
|
2014-02-04 |
2017-07-12 |
Micro-nature LLC |
Systems, methods, and compositions relating to combiomics
|
US20160354509A1
(en)
|
2014-02-10 |
2016-12-08 |
The Johns Hopkins University |
Devices for and methods of treatment of metabolic syndromes
|
BR112016018283A2
(pt)
|
2014-02-14 |
2017-08-08 |
Vesale Pharma Sa |
Composição que compreende bifidobacterium animalis ssp. lactis
|
WO2015131076A1
(en)
|
2014-02-27 |
2015-09-03 |
Yale University |
Nlrp6 inflammasome intestinal epithelium mucus secretion
|
US20150246081A1
(en)
|
2014-03-03 |
2015-09-03 |
Shayne Kenneth Morris |
Probiotics with methods for growth and use separately and in combination
|
US20150374760A1
(en)
|
2014-04-09 |
2015-12-31 |
Jose U. Scher |
Methods for treating psoriasis and psoriatic arthritis
|
PL3138031T3
(pl)
|
2014-04-28 |
2023-04-11 |
Yeda Research And Development Co., Ltd. |
Sposób i urządzenie do przewidywania odpowiedzi na pokarm
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
FI127483B
(en)
|
2014-06-11 |
2018-07-13 |
Gut Guide Oy |
Microbial marker for celiac disease and related product
|
MX2014009044A
(es)
|
2014-07-25 |
2016-01-25 |
Polioles S A De C V |
Nuevas moléculas derivadas de 2-fenil-imidazolinas fosforiladas, con alta estabilidad del anillo imidazolina y alta efectividad como inhibidores de corrosión.
|
BR112017002627A2
(pt)
|
2014-08-18 |
2017-12-05 |
Nestec Sa |
prebióticos para reduzir o risco de obesidade no futuro
|
US10410749B2
(en)
|
2014-10-21 |
2019-09-10 |
uBiome, Inc. |
Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
|
US9710606B2
(en)
|
2014-10-21 |
2017-07-18 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
|
US9760676B2
(en)
|
2014-10-21 |
2017-09-12 |
uBiome, Inc. |
Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
|
WO2016065324A1
(en)
|
2014-10-24 |
2016-04-28 |
Evolve Biosystems Inc. |
Activated bifidobacteria and methods of use thereof
|
WO2016065419A1
(en)
|
2014-10-28 |
2016-05-06 |
Medlab Ip Pty Ltd |
Treatment for depression and depressive disorders
|
EP3212001A4
(en)
*
|
2014-10-31 |
2018-04-25 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
CA2967233A1
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Method of analyzing microbiome
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
WO2016084029A1
(en)
|
2014-11-26 |
2016-06-02 |
Probiotical S.P.A. |
Strains of lactobacillus or bifidobacterium for maintaining homeostasis
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
WO2016110585A1
(en)
|
2015-01-09 |
2016-07-14 |
Wageningen Universiteit |
Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases
|
AU2016209244A1
(en)
|
2015-01-23 |
2017-08-17 |
Helena M.G.P.V. Reis |
Use of short chain fatty acids in cancer prevention
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
SG10202002010VA
(en)
|
2015-03-13 |
2020-05-28 |
Evolve Biosystems Inc |
Compositions that metabolize or sequester free sugar monomers and uses thereof
|
EP3270938A4
(en)
|
2015-03-18 |
2018-12-19 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
EP3289093A4
(en)
|
2015-04-28 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
USE OF MICROBIAL METABOLITES FOR THE TREATMENT OF DISEASES
|
WO2016176380A1
(en)
|
2015-04-28 |
2016-11-03 |
The Procter & Gamble Company |
Compositions comprising whole, non-viable micrococcus for improving skin health
|
DK3292135T3
(da)
|
2015-05-06 |
2022-10-31 |
Univ Wageningen |
Anvendelse af et polypeptid til at fremkalde immunsignalering og/eller påvirke tarmbarrierefunktion og/eller modulere metabolsk status
|
KR102615649B1
(ko)
|
2015-05-06 |
2023-12-19 |
바게닝겐 유니버시테이트 |
아커만시아의 배양 방법
|
EA201792547A1
(ru)
|
2015-05-21 |
2018-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Популяции бактерий для стимуляции состояния здоровья
|
KR101589464B1
(ko)
|
2015-05-21 |
2016-02-01 |
주식회사 쎌바이오텍 |
신규한 비피더스 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물
|
KR101589466B1
(ko)
|
2015-05-21 |
2016-02-01 |
주식회사 쎌바이오텍 |
성장 촉진을 위한 비피도박테리움 롱굼 cbt bg7 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물
|
AU2016272114B2
(en)
|
2015-05-30 |
2019-09-12 |
Japan Eco-Science Co., Ltd. |
Probiotic or prebiotic, method for producing same, microbial preparation, health food, and medicine
|
CN107921073B
(zh)
|
2015-06-01 |
2022-10-18 |
塞诺生物科学股份有限公司 |
用于调节肠道微生物群及管理体重的方法和组合物
|
US20160355847A1
(en)
|
2015-06-03 |
2016-12-08 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Novel Clostridium Species That Converts Wheat Straw and Switchgrass Hydrolysates Into Butyric Acid
|
US20180153944A1
(en)
|
2015-06-09 |
2018-06-07 |
Regents Of The University Of Minnesota |
Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
|
GB201514303D0
(en)
|
2015-07-16 |
2015-09-23 |
Dupont Nutrition Biosci Aps |
Bifidobacteria for treating cardiac conditions
|
AU2016297986B8
(en)
|
2015-07-29 |
2020-06-11 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
WO2017024237A1
(en)
|
2015-08-06 |
2017-02-09 |
The Johns Hopkins University |
Composition and method for treatment of metabolic disorders
|
US10300043B2
(en)
|
2015-08-12 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof
|
CN105106245A
(zh)
|
2015-08-24 |
2015-12-02 |
上海交通大学医学院附属瑞金医院 |
Akkermansia muciniphila BAA-835菌株的应用
|
EP3341000A4
(en)
|
2015-08-24 |
2019-02-20 |
Nubyiota LLC |
SYSTEMS AND METHODS FOR THE TREATMENT OF DYSBIOSIS USING BACTERIAL POPULATIONS DERIVED FROM FECES
|
CN105030841A
(zh)
|
2015-08-24 |
2015-11-11 |
上海交通大学医学院附属瑞金医院 |
Akkermansia muciniphila BAA-835菌株的应用
|
WO2017035412A1
(en)
|
2015-08-25 |
2017-03-02 |
Kaleido Biosciences, Inc. |
Glycan compositions and uses thereof
|
CA2995393A1
(en)
|
2015-08-27 |
2017-03-02 |
Alimentary Health Ltd. |
Bifidobacterium longum
|
US20180280453A1
(en)
|
2015-08-27 |
2018-10-04 |
Alimentary Health Limited |
Use of bifidobacterium longum and an exopolysaccharide produced thereby
|
ES2943714T3
(es)
|
2015-09-04 |
2023-06-15 |
Memorial Sloan Kettering Cancer Center |
Métodos para detectar riesgo de recidiva de cáncer usando Eubacterium limosum
|
PT3626081T
(pt)
|
2015-09-10 |
2022-02-25 |
Univ Catholique Louvain |
Akkermansia pasteurizada para promover a perda de peso
|
WO2017047968A1
(ko)
|
2015-09-15 |
2017-03-23 |
경희대학교 산학협력단 |
다양한 기능성을 가진 신규 유산균 및 이의 용도
|
US10537597B2
(en)
|
2015-10-05 |
2020-01-21 |
Schweizerisches Forschungsinstitut Fur Hochgebrigsklima Und Medizin In Davos |
Use of Akkermansia muciniphila for treating inflammatory conditions
|
EP3359174A1
(en)
|
2015-10-07 |
2018-08-15 |
Galderma Research & Development |
Composition containing lactic acid bacteria and its use to treat atopic dermatitis
|
CA3001920A1
(en)
|
2015-10-15 |
2017-04-20 |
Natura Cosmeticos S.A. |
Cosmetic composition having probiotic bacteria
|
CN108472315A
(zh)
|
2015-10-26 |
2018-08-31 |
克雷斯顿沃控股公司 |
用于粪便微生物群相关疗法的组合物及方法
|
IL277648B2
(en)
|
2015-11-03 |
2023-04-01 |
Brigham & Womens Hospital Inc |
Medical microbiota for the treatment and/or prevention of food allergy
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
EP4233884A3
(en)
|
2015-11-24 |
2023-10-04 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
US9668991B1
(en)
|
2015-12-09 |
2017-06-06 |
International Business Machines Corporation |
SCFA colonic composition
|
US10973862B2
(en)
|
2015-12-11 |
2021-04-13 |
Precisionbiotics Group Limited |
Bifidobacterium longum for treating obesity and associated metabolic disorders
|
WO2017105990A1
(en)
|
2015-12-14 |
2017-06-22 |
Massachusetts Institute Of Technology |
Ph-responsive mucoadhesive polymeric encapsulated microorganisms
|
EP3389680B1
(en)
|
2015-12-14 |
2023-10-11 |
Metabogen AB |
Treatment of intrahepatic cholestasis and related liver diseases
|
JPWO2017130859A1
(ja)
|
2016-01-28 |
2018-11-15 |
森永乳業株式会社 |
神経細胞死抑制剤
|
CN108712906B
(zh)
|
2016-02-04 |
2023-06-30 |
根特大学 |
微生物群落用于人类和动物健康的用途
|
JP7012651B2
(ja)
|
2016-02-25 |
2022-01-28 |
カエルス ファーマシューティカルズ ビー.ヴィ. |
ビタミンb12欠乏症を予防および/または治療するための組成物および方法
|
WO2017159643A1
(ja)
|
2016-03-14 |
2017-09-21 |
物産フードサイエンス株式会社 |
腸内酪酸増加剤および酪酸産生菌増殖剤
|
EP3551201A4
(en)
|
2016-12-06 |
2020-06-24 |
Pendulum Therapeutics, Inc. |
METHOD AND COMPOSITIONS RELATING TO INSULATED AND CLEANED MICROBES
|
US20180357375A1
(en)
|
2017-04-04 |
2018-12-13 |
Whole Biome Inc. |
Methods and compositions for determining metabolic maps
|
JP2020530840A
(ja)
|
2017-08-14 |
2020-10-29 |
セレス セラピューティクス インコーポレイテッド |
胆汁うっ滞性疾患を治療するための組成物及び方法
|
EP3675882A4
(en)
|
2017-08-30 |
2021-07-28 |
Pendulum Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
|
GB2593600A
(en)
|
2018-09-24 |
2021-09-29 |
Pendulum Therapeutics Inc |
Microbial compositions and methods of use
|
WO2020236979A1
(en)
|
2019-05-21 |
2020-11-26 |
Pendulum Therapeutics, Inc. |
Methods and compositions for treating liver disorders
|
CA3162695A1
(en)
|
2019-12-23 |
2021-07-01 |
Nicholas B. Justice |
Compositions comprising microbes and methods of use and making thereof
|